About: COVID-19: IFSO LAC Recommendations for the Resumption of Elective Bariatric Surgery

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: COVID-19: IFSO LAC Recommendations for the Resumption of Elective Bariatric Surgery Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : wasabi.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	COVID-19: IFSO LAC Recommendations for the Resumption of Elective Bariatric Surgery
Creator	Lima, Peru Aparicio, Sergio Behrens, Estuardo Camacho, Diego Laynez, Jorge Marcos, San Martínez Duartez, Pedro Poggi, Luis Ramos, Almino Rodríguez, Nelson Zundel, Natan Almino, & Antonio López-Corvalá, Juan Cardoso, Ramos Leão Vilas-Bôas, Marcos
Source	Medline; PMC
abstract	BACKGROUND: COVID-19 pandemic varies greatly and has different dynamics in every country, city, and hospital in Latin America. Obesity increases the risk of SARS-CoV-2 infection, and it is one of the independent risk factors for the most severe cases of COVID-19. Currently, the most effective treatment against obesity available is bariatric and metabolic surgery (BMS), which further resolves or improves other independent risk factors like diabetes and hypertension. OBJECTIVE: Provide recommendations for the resumption of elective BMS during COVID-19 pandemic. METHOD: This document was created by the IFSO-LAC Executive Board and a task force. Based on data collected from a survey distributed to all IFSO-LAC members that obtained 540 responses, current evidence available, and consensus reached by other scientific societies. RESULTS: The resumption of elective BMS must be a priority maybe similar to oncological surgery, when hospitals reach phase I or II, treating obesity patients in a NON-COVID area, avoiding inadvertent intrahospital contagion from healthcare provider, patients, and relatives. Same BMS indication and types of procedures as before the pandemic. Discard the presence of SARS-CoV-2 within 72 h prior to surgery. Continues laparoscopic approach. The entire team use N95 mask. Minimum hospital stays. Implement remote visits for the follow-up. CONCLUSION: Resumption of elective BMS is crucial because it is not only a weight loss operation but also resolves or improves comorbidities and appears to be an immune restorative procedure of obese patients in the medium term, offering them the same probability of contracting COVID-19 as the regular population.
has issue date	2020-08-22(xsd:dateTime)
bibo:doi	10.1007/s11695-020-04910-9
bibo:pmid	32827292
has license	no-cc
sha1sum (hex)	8aecb220d547a3830169149fd7273472715fe2e2
schema:url	https://doi.org/10.1007/s11695-020-04910-9
resource representing a document's title	COVID-19: IFSO LAC Recommendations for the Resumption of Elective Bariatric Surgery
has PubMed Central identifier	PMC7442889
has PubMed identifier	32827292
schema:publication	Obes Surg
resource representing a document's body	covid:8aecb220d547a3830169149fd7273472715fe2e2#body_text
is schema:about of	named entity 'patients' named entity 'BMS' named entity 'elective' named entity 'obese' named entity 'REGULAR' named entity 'DIFFERENT' named entity 'N95 MASK' named entity 'AVAILABLE' named entity 'PRESENCE OF' named entity 'reach' named entity 'operation' named entity 'procedure' named entity 'task force' named entity 'cases' named entity 'varies' named entity 'BMS' named entity 'SARS-CoV-2' named entity 'COVID' named entity 'medical treatment' named entity 'distributed' named entity 'avoiding' named entity 'follow-up' named entity 'SARS-CoV-2' named entity 'metabolic' named entity 'weight loss' named entity 'obese' named entity 'COVID-19 pandemic' named entity 'risk factors' named entity 'hospital stays' named entity 'Bariatric Surgery' named entity 'COVID-19' named entity 'resolves' named entity 'infection' named entity 'metabolic' named entity 'informed consent' named entity 'face masks' named entity 'China' named entity 'ultraviolet radiation' named entity 'SARS-CoV-2 virus' named entity 'SARS-CoV-2' named entity 'SARS-CoV-2' named entity 'N95' named entity 'obesity' named entity 'attending physician' named entity 'metabolic' named entity 'virus' named entity 'CD14' named entity 'morbidly obese' named entity 'fatality rate' named entity 'metabolic' named entity 'ultrafiltration' named entity 'insufflation' named entity 'mortality rates' named entity 'twenty-first century' named entity 'lose weight' named entity 'SARS-CoV-2' named entity 'BMI' named entity 'neutrophil' named entity 'Spain' named entity 'insufflator' named entity 'infection' named entity 'health systems' named entity 'internist' named entity 'comorbidities' named entity 'epidemic' named entity 'obesity' named entity 'SARS-CoV-2 outbreak'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software